7 aad staining solution (Miltenyi Biotec)
Structured Review
7 Aad Staining Solution, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 81 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/staining+solution/7-AAD+Staining+Solution/pmc13409855-64-0-6
Average 97 stars, based on 81 article reviews
Images
Related Articles
Staining:Article Title: Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke. Article Snippet: .. For purity assessment, cells were stained with mouse anti-CD31-PE (130-111-540; Miltenyi), antiCD45-VioGreen (130-110-803; Miltenyi), and Article Title: Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. Article Snippet: The samples were run on a MACSQuant 10 flow cytometer (Miltenyi Biotec, Germany), and the data were analyzed with FlowJo software version 10. .. Cell viability was assessed using Article Title: Interleukin-2-Mediated Engraftment of Human Peripheral Blood Mononuclear Cells in Immunodeficient Mice to Develop a Model of HIV Infection: New Criteria for Engraftment Monitoring Article Snippet: .. Article Title: Method for transduction of t cells in the presence of malignant cells Article Snippet: .. After binding for 1 h at 4° C., excess LV was removed by one washing step and staining was performed with Isolation:Article Title: Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. Article Snippet: The samples were run on a MACSQuant 10 flow cytometer (Miltenyi Biotec, Germany), and the data were analyzed with FlowJo software version 10. .. Cell viability was assessed using Exclusion Assay:Article Title: Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. Article Snippet: The samples were run on a MACSQuant 10 flow cytometer (Miltenyi Biotec, Germany), and the data were analyzed with FlowJo software version 10. .. Cell viability was assessed using FACS:Article Title: Proinflammatory Cytokine Preconditioning Enhances the Therapeutic Potency of Different Types of MSCs in Inflammation. Article Snippet: The PBMCs were stained with anti-human CD3-APC-Vio770, CD4-APC and CD8-PE-Vio770 antibodies (Cat# 130-113-136, 130-113-222, 130-110-680; Miltenyi Biotec) for 30 min on ice in the dark. .. After being washed with FACS buffer, the cells were incubated with Incubation:Article Title: Proinflammatory Cytokine Preconditioning Enhances the Therapeutic Potency of Different Types of MSCs in Inflammation. Article Snippet: The PBMCs were stained with anti-human CD3-APC-Vio770, CD4-APC and CD8-PE-Vio770 antibodies (Cat# 130-113-136, 130-113-222, 130-110-680; Miltenyi Biotec) for 30 min on ice in the dark. .. After being washed with FACS buffer, the cells were incubated with Blocking Assay:Article Title: Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Human Mobilized Peripheral Blood for Gene Therapy Applications. Article Snippet: .. 1166 Antibody Fluorochrome Clone Company Code FcR Blocking Reagent - - Miltenyi Biotec 130-059-901 CD45 APC-eFluor780 HI30 eBioscience 47-0459-42 CD45 VioBlue clone REA747 Miltenyi 170-081-077 CD19 PE-Cy7 HIB19 BioLegend 302216 CD19 PE clone SJ25C1 BD Biosciences 345789 CD3 PE SK7 BD Biosciences 345765 CD3 PB UCHT1 BioLegend 300431 CD13 APC WM15 BD Biosciences 557454 CD33 APC AC104.3E3 Miltenyi Biotec 130-091-731 CD33 PE-Cy7 P67.6 BD Biosciences 333952 CD33 APC-Vio770 clone REA775 Miltenyi Biotec 130-111-022 CD34 VioBlue AC136 Miltenyi Biotec 130-095-393 CD34 PE-Cy7 clone 8G12 BD Biosciences 348811 CD34 APC AC136 Miltenyi Biotec 130-120-519 CD34 BV421 BioLegend 343610 CD34 PE Clone AC136 Miltenyi Biotec 130-113-179 Jo urn al Pr -pr oo f 45 CD38 PE-Vio770 IB6 Miltenyi Biotec 130-099-151 CD90 APC 5E10 BD Biosciences 559869 CD90 BV421 5E10 BD Biosciences 562556 CD45RA PE T6D11 Miltenyi Biotec 130-092-248 CD45RA FITC clone HI100 BioLegend 304106 CD56 PE clone NCAM 16.2 BD Biosciences 345812 BAH1 PE BAH-1 BD Biosciences 565746 CD71 BV711 M-A712 BD Biosciences 563767 CD49f PC5 GoH3 BD Biosciences 562495 7AAD - - Miltenyi Biotec Labeling:Article Title: Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Human Mobilized Peripheral Blood for Gene Therapy Applications. Article Snippet: .. 1166 Antibody Fluorochrome Clone Company Code FcR Blocking Reagent - - Miltenyi Biotec 130-059-901 CD45 APC-eFluor780 HI30 eBioscience 47-0459-42 CD45 VioBlue clone REA747 Miltenyi 170-081-077 CD19 PE-Cy7 HIB19 BioLegend 302216 CD19 PE clone SJ25C1 BD Biosciences 345789 CD3 PE SK7 BD Biosciences 345765 CD3 PB UCHT1 BioLegend 300431 CD13 APC WM15 BD Biosciences 557454 CD33 APC AC104.3E3 Miltenyi Biotec 130-091-731 CD33 PE-Cy7 P67.6 BD Biosciences 333952 CD33 APC-Vio770 clone REA775 Miltenyi Biotec 130-111-022 CD34 VioBlue AC136 Miltenyi Biotec 130-095-393 CD34 PE-Cy7 clone 8G12 BD Biosciences 348811 CD34 APC AC136 Miltenyi Biotec 130-120-519 CD34 BV421 BioLegend 343610 CD34 PE Clone AC136 Miltenyi Biotec 130-113-179 Jo urn al Pr -pr oo f 45 CD38 PE-Vio770 IB6 Miltenyi Biotec 130-099-151 CD90 APC 5E10 BD Biosciences 559869 CD90 BV421 5E10 BD Biosciences 562556 CD45RA PE T6D11 Miltenyi Biotec 130-092-248 CD45RA FITC clone HI100 BioLegend 304106 CD56 PE clone NCAM 16.2 BD Biosciences 345812 BAH1 PE BAH-1 BD Biosciences 565746 CD71 BV711 M-A712 BD Biosciences 563767 CD49f PC5 GoH3 BD Biosciences 562495 7AAD - - Miltenyi Biotec Binding Assay:Article Title: Method for transduction of t cells in the presence of malignant cells Article Snippet: .. After binding for 1 h at 4° C., excess LV was removed by one washing step and staining was performed with |
